Author | MD Magazine® Staff


FDA Approves Ubrogepant for Acute Migraine in Adults

December 24, 2019

The oral CGRP antagonist becomes the first in its class approved for the indication.

FDA Approves Lemborexant for Insomnia in Adults

December 23, 2019

The small molecule orexin receptor antagonist will be made available for the US market in 2 different doses, in 2020.

FDA Approves Golodirsen Injection for DMD with Genetic Mutations

December 13, 2019

The approval comes 4 months following a Complete Response Letter was submitted and successfully disputed, to Sarepta Therapeutics.

FDA Approves Botox for Lower Limb Spasticity in Pediatric Patients

October 25, 2019

The FDA approves Botox injections to treat pediatric patients with both upper and lower limb spasticity, unless it was caused by cerebral palsy.